Tag: BARDA Contract
March 19, 2018
MediWound Reports Fourth Quarter and Fiscal Year 2017 Financial Results
MediWound (Nasdaq:MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, today... September 26, 2017
Aeolus Announces Presentation of Pharmacometric Analysis
Aeolus Pharmaceuticals announced the presentation of new data on AEOL 10150 for the treatment of the pulmonary effects of acute... April 10, 2017